(Q51894485)

17 April 2018

title

When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? (English)

1 reference

17 April 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

Stephen Franks

1

1 reference

17 April 2018

publication date

1 February 2011

1 reference

17 April 2018

published in

Clinical Endocrinology

1 reference

17 April 2018

volume

74

1 reference

17 April 2018

issue

2

1 reference

17 April 2018

page(s)

148-151

1 reference

17 April 2018

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Insulin action in the normal and polycystic ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Follicle dynamics and anovulation in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Metformin in polycystic ovary syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Consensus on infertility treatment related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2010.03934.X

10.1111/J.1365-2265.2010.03934.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018